[Secondary Neuroprotection in Glaucoma by Reduction of Intraocular Pressure].

[Secondary Neuroprotection in Glaucoma by Reduction of Intraocular Pressure].

Unterlauft, Jan Darius;
klinische monatsblatter fur augenheilkunde 2019
279
unterlauft2019secondaryklinische

Abstract

The central goal of glaucoma treatment is the reduction of intraocular pressure (IOP) by means of medication and/or surgery, in order to prevent further disease progression for as long as possible. Stabilising visual field defects and saving papillary neural tissue are seen as the optimal achievable aims in glaucoma therapy. We performed a systematic literature search and analysis of the published articles dealing with neuroprotection and functional improvement by IOP reduction in glaucoma. On this basis, the known options for anatomical and functional recovery of formerly lost structures and functions will be elucidated. Several studies - some large - have provided evidence for anatomical improvement at the optic nerve head and functional improvement in the results of visual field tests. After glaucoma treatment, there is anatomical and functional improvement in some patients. However, improvement is mostly detectable in patients whose IOP was greatly reduced.

Citation

ID: 67638
Ref Key: unterlauft2019secondaryklinische
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
67638
Unique Identifier:
10.1055/a-1023-4464
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet